Christian KA, Ijaz K, Dowell SF, Chow CC, Chitale RA, Bresee JS, Mintz E, Pallansch MA, Wassilak S, McCray E, Arthur RR: What we are watching—five top global infectious disease threats, 2012: a perspective from CDC’s Global Disease Detection Operations Center. Emerg Health Threats J. 2013, 6: 663-
Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, Shih SR, Ning HC, Hwang MS, Wang HS, Lee CY: Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999, 354: 1682-1686.
McMinn P, Stratov I, Nagarajan L, Davis S: Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 2001, 32: 236-242.
Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF: Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999, 341: 936-942.
Chang L-Y, Huang L-M, Gau SS-F, Wu Y-Y, Hsia S-H, Fan T-Y, Lin K-L, Huang Y-C, Lu C-Y, Lin T-Y: Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. 2007, 356: 1226-1234.
Gau SS-F, Chang L-Y, Huang L-M, Fan T-Y, Wu Y-Y, Lin T-Y: Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system. Pediatrics. 2008, 122: e452-e458.
Chang L-Y, Tsao K-C, Hsia S-H, Shih S-R, Huang C-G, Chan W-K, Hsu K-H, Fang T-Y, Huang Y-C, Lin T-Y: Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA. 2004, 291: 222-227.
Ooi MH, Wong SC, Mohan A, Podin Y, Perera D, Clear D, Del Sel S, Chieng CH, Tio PH, Cardosa MJ, Solomon T: Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis. 2009, 9: 3-
Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT: Epidemiology and control of hand, foot and mouth disease in Singapore, 2001–2007. Ann Acad Med Singapore. 2009, 38: 106-112.
Liu CC, Tseng HW, Wang SM, Wang JR, Su IJ: An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. J Clin Virol. 2000, 17: 23-30.
Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, Chen YJ, Yang YJ, Lin SJ, Yeh TF: Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 1999, 29: 184-190.
Lee M-S, Lin T-Y, Chiang P-S, Li W-C, Luo S-T, Tsao K-C, Liou G-Y, Huang M-L, Hsia S-H, Huang Y-C, Chang S-C: An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr Infect Dis J. 2010, 29: 1030-1034.
Chia M-Y, Chiang P-S, Chung W-Y, Luo S-T, Lee M-S: Epidemiology of Enterovirus 71 Infections in Taiwan. Pediatr Neonatol. 2013, doi:10.1016/j.pedneo.2013.07.007. [Epub ahead of print]
Huang K-Y, Zhang X, Chung P-H, Tsao K-C, Lin T-Y, Su L-H, Chiu C-H: Enterovirus 71 in Taiwan, 2004–2006: epidemiological and virological features. Scand J Infect Dis. 2008, 40: 571-574.
Chang L-Y: Enterovirus 71 in Taiwan. Pediatr Neonatol. 2008, 49: 103-112.
Chen K-T, Chang H-L, Wang S-T, Cheng Y-T, Yang J-Y: Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998–2005. Pediatrics. 2007, 120: e244-e252.
Ruan F, Yang T, Ma H, Jin Y, Song S, Fontaine RE, Zhu B-P: Risk factors for hand, foot, and mouth disease and herpangina and the preventive effect of hand-washing. Pediatrics. 2011, 127: e898-e904.
Chang L-Y, Hsia S-H, Wu C-T, Huang Y-C, Lin K-L, Fang T-Y, Lin T-Y: Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr Infect Dis J. 2004, 23: 327-332.
Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH: Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010, 10: 778-790.
Shih SR, Stollar V, Li ML: Host factors in enterovirus 71 replication. J Virol. 2011, 85: 9658-9666.
Huang H-I, Weng K-F, Shih S-R: Viral and host factors that contribute to pathogenicity of enterovirus 71. Future Microbiol. 2012, 7: 467-479.
Chang LY, King CC, Hsu KH, Ning HC, Tsao KC, Li CC, Huang YC, Shih SR, Chiou ST, Chen PY, Chang HJ, Lin TY: Risk Factors of Enterovirus 71 Infection and Associated Hand, Foot, and Mouth Disease/Herpangina in Children During an Epidemic in Taiwan. Pediatrics. 2002, 109: e88-e88.
Zhang G, Zhou F, Gu B, Ding C, Feng D, Xie F, Wang J, Zhang C, Cao Q, Deng Y, Hu W, Yao K: In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch Virol. 2012, 157: 669-679.
Pourianfar HR, Grollo L: Development of antiviral agents toward enterovirus 71 infection. J Microbiol Immunol Infect. 2014, doi:10.1016/j.jmii.2013.11.011. [Epub ahead of print]
Zhang Y, Cui W, Liu L, Wang J, Zhao H, Liao Y, Na R, Dong C, Wang L, Xie Z, Gao J, Cui P, Zhang X, Li Q: Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab Invest. 2011, 91: 1337-1350.
Tsai Y-C, Lin C-H, Huang W-T, Yeh N-C, Kuo H-W, Chuang J-H: The Epidemic of Enterovirus 71 in Taiwan, 2011–2012. Taiwan Epidemiol Bull. 2012, 28: 79-81.
Iturriza-Gómara M, Megson B, Gray J: Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing. J Med Virol. 2006, 78: 243-253.
Hsia S-H, Wu C-T, Chang J-J, Lin T-Y, Chung H-T, Lin K-L, Hwang M-S, Chou M-L, Chang L-Y: Predictors of unfavorable outcomes in enterovirus 71-related cardiopulmonary failure in children. Pediatr Infect Dis J. 2005, 24: 331-334.
Kim SJ, Kim J-H, Kang J-H, Kim DS, Kim KH, Kim K-H, Kim Y-H, Chung J-Y, Bin JH, Jung DE, Kim JH, Kim HM, Cheon D-S, Kang BH, Seo SY, The Enteroviruses Complications Working Group: Risk factors for neurologic complications of hand, foot and mouth disease in the Republic of Korea, 2009. J Korean Med Sci. 2013, 28: 120-
Hsu C-H, Lu C-Y, Shao P-L, Lee P-I, Kao C-L, Chung M-Y, Chang L-Y, Huang L-M: Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008. J Microbiol Immunol Infect. 2011, 44: 265-273.
Li C-C, Yang M-Y, Chen R-F, Lin T-Y, Tsao K-C, Ning H-C, Liu H-C, Lin S-F, Yeh W-T, Chu Y-T, Yang KD: Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in southern Taiwan. Scand J Infect Dis. 2002, 34: 104-109.
Yang T-T, Huang L-M, Lu C-Y, Kao C-L, Lee W-T, Lee P-I, Chen C-M, Huang F-Y, Lee C-Y, Chang L-Y: Clinical features and factors of unfavorable outcomes for non-polio enterovirus infection of the central nervous system in northern Taiwan, 1994–2003. J Microbiol Immunol Infect. 2005, 38: 417-424.
Balfour HH, Odumade OA, Schmeling DO, Mullan BD, Ed JA, Knight JA, Vezina HE, Thomas W, Hogquist KA: Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis. 2013, 207: 80-88.
Sia IG, Wilson JA, Groettum CM, Espy MJ, Smith TF, Paya CV: Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. J Infect Dis. 2000, 181: 717-720.
Humar A, Gregson D, Caliendo AM, McGeer A, Malkan G, Krajden M, Corey P, Greig P, Walmsley S, Levy G, Mazzulli T: Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation. 1999, 68: 1305-1311.
Guilarde AO, Turchi MD, Siqueira JB, Feres VCR, Rocha B, Levi JE, Souza VAUF, Boas LSV, Pannuti CS, Martelli CMT: Dengue and Dengue Hemorrhagic Fever among Adults: Clinical Outcomes Related to Viremia, Serotypes, and Antibody Response. J Infect Dis. 2008, 197: 817-824.
Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A: Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000, 181: 2-9.
Fumian TM, Justino MCA, D’Arc Pereira Mascarenhas J, Reymão TKA, Abreu E, Soares L, Linhares AC, Gabbay YB: Quantitative and molecular analysis of noroviruses RNA in blood from children hospitalized for acute gastroenteritis in Belém, Brazil. J Clin Virol. 2013, 58: 31-35.
Pettersson L, Thunberg T, Rocklöv J, Klingström J, Evander M, Ahlm C: Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients-implications for treatment. Clin Microbiol Infect. 2013, 20: 235-241.
Kung C-M, King C-C, Lee C-N, Huang L-M, Lee P-I, Kao C-L: Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan. J Med Virol. 2006, 79: 60-68.
Chung PW, Huang YC, Chang LY, Lin TY, Ning HC: Duration of enterovirus shedding in stool. J Microbiol Immunol Infect. 2001, 34: 167-170.
Wang S-M, Lei H-Y, Huang K-J, Wu J-M, Wang J-R, Yu C-K, Su I-J, Liu C-C: Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 2003, 188: 564-570.
Huang M-L, Chiang P-S, Chia M-Y, Luo S-T, Chang L-Y, Lin T-Y, Ho M-S, Lee M-S: Cross-reactive Neutralizing Antibody Responses to Enterovirus 71 Infections in Young Children: Implications for Vaccine Development. PLoS Negl Trop Dis. 2013, 7: e2067-